Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LongGame is a venture capital organization established to fund radical lifespan extension through investments in longevity biotech companies. Based in the United States, LongGame focuses on developing technologies that can significantly extend healthy human lifespan. The organization is dedicated to advancing the field of longevity, targeting a minimum increase of 10 years in healthy lifespan through its investments.
While specific quantitative metrics such as fund size, portfolio count, or team size are not disclosed, LongGame is recognized for its commitment to scalable solutions that benefit global populations rather than just the wealthy. The organization aims to create a significant impact in the biotech sector by supporting innovative startups that align with its mission.
LongGame invests exclusively in technologies designed to extend human life beyond current limits. The organization emphasizes scalable solutions that can benefit global populations, ensuring that advancements in longevity are accessible to a wider audience. Its investment thesis encompasses various biotech fields, including AI, synthetic biology, stem cell therapies, gene sequencing and editing, protein engineering, and tissue engineering.
LongGame seeks to partner with companies that are developing novel and cutting-edge approaches to life extension. The firm is particularly interested in technologies that can achieve a minimum increase of 10 years in healthy lifespan, reflecting its commitment to radical advancements in the field of longevity.
LongGame's portfolio includes companies that are pioneering innovative approaches to life extension. While specific names and descriptions of these companies are not provided, the organization is known for supporting ventures that align with its mission of extending healthy human lifespan. The focus on novel technologies in the biotech sector positions LongGame as a key player in the longevity investment space.
Investments are directed towards startups that are developing scalable solutions in various biotech fields, ensuring that the impact of their innovations can reach a broad audience. This strategic focus on life extension technologies underscores LongGame's commitment to advancing the science of longevity.
What are LongGame's investment criteria?
LongGame invests in technologies that aim to extend human life by a minimum of 10 years. The organization focuses on scalable solutions that benefit global populations, particularly in the biotech sector.
How can startups apply or pitch to LongGame?
Startups interested in partnering with LongGame should reach out through their website for inquiries related to investment. Specific application forms or portals are not mentioned.
What makes LongGame different from other venture capital firms?
LongGame is distinct in its exclusive focus on radical lifespan extension and its commitment to funding technologies that can significantly increase healthy human lifespan. This targeted approach sets it apart in the venture capital landscape.
What is LongGame's geographic scope?
LongGame is based in the United States and primarily invests in companies within the country that are focused on longevity biotech.
What kind of post-investment involvement does LongGame have?
Details regarding post-investment involvement are not specified, but LongGame is known for supporting innovative startups in the longevity sector.
What is the typical check size for investments made by LongGame?
Specific check sizes are not disclosed, but LongGame focuses on funding technologies that align with its mission of extending human lifespan.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.